Tech Company Financing Transactions

Fibrocor Therapeutics Funding Round

Fibrocor Therapeutics closed a $2.1 million venture capital round on 1/18/2017. Investors included Mars and private investors.

Transaction Overview

Announced On
1/18/2017
Transaction Type
Venture Equity
Amount
$2,100,000
Round
Undisclosed
Investors

Mars

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Toronto ON, M4B 1B6
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Fibrocor Therapeutics is focused on developing disease modifying therapeutics in fibrosis. The company has already identified a lead program and will partner with Evotec to develop novel molecules.
Profile
Fibrocor Therapeutics LinkedIn Company Profile
Social Media
Fibrocor Therapeutics Company Twitter Account
Company News
Fibrocor Therapeutics News
Facebook
Fibrocor Therapeutics on Facebook
YouTube
Fibrocor Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Co-Founder
Richard Gilbert
  Richard Gilbert LinkedIn Profile  Richard Gilbert Twitter Account  Richard Gilbert News  Richard Gilbert on Facebook
Co-Founder
Jeff Wrana
  Jeff Wrana LinkedIn Profile  Jeff Wrana Twitter Account  Jeff Wrana News  Jeff Wrana on Facebook
Co-Founder
Darren Yuen
  Darren Yuen LinkedIn Profile  Darren Yuen Twitter Account  Darren Yuen News  Darren Yuen on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/18/2017: Tokyo Smoke venture capital transaction
Next: 1/18/2017: Hypori venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary